Net Loss per Share (Tables)

9 Months Ended

Sep. 30, 2022

Net Loss per Share

Summary of Outstanding Potentially Dilutive Common Stock Equivalents have been Excluded from the Calculation of Diluted Net Loss Per Share

The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods presented due to their antidilutive effect:

	Nine Months Ended
	September 30,
	2022		2021
Convertible preferred stock (as converted)		—		2,227,116
Warrants to purchase common stock		272,680		50,000
Common stock options issued and outstanding		1,248,850		376,969
Total		1,521,530		2,654,085